Evidence map›Paper›PMID 29416686›Full record

ArticleOncotarget2018

Exosomes released by metabotropic glutamate receptor 1 (GRM1) expressing melanoma cells increase cell migration and invasiveness.

Allison L Isola, Kevinn Eddy, Krzysztof Zembrzuski, James S Goydos, Suzie Chen

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. G protein-coupled receptors: a gateway to targeting oncogenic EVs?Extracellular vesicles and circulating nucleic acids · 2024
    Review
  6. Review
  7. Review
  8. Review
  9. Exosome application in tumorigenesis: diagnosis and treatment of melanoma.Medical oncology (Northwood, London, England) · 2022
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Overcoming Immune Evasion in Melanoma.International journal of molecular sciences · 2020
    Review
  15. Signaling of Tumor-Derived sEV Impacts Melanoma Progression.International journal of molecular sciences · 2020
    Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Allison L IsolaSusan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University, Piscataway, NJ 08854, USA.
Kevinn EddySusan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University, Piscataway, NJ 08854, USA.
Krzysztof ZembrzuskiSusan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University, Piscataway, NJ 08854, USA.
James S GoydosRutgers Cancer Institute of New Jersey, New Brunswick, NJ 08901, USA.
Suzie ChenSusan Lehman Cullman Laboratory for Cancer Research, Ernest Mario School of Pharmacy, Rutgers, The State University, Piscataway, NJ 08854, USA.
Rutgers, The State University of New Jersey · USRutgers Cancer Institute of New Jersey

Funding

Summer Research Training in Environmental Health SciencesR25ES020721 · NIEHS · RUTGERS, THE STATE UNIV OF N.J. · PI Lauren M Aleksunes, Debra L Laskin · 2011 to 2026
$1.2M
Regulation of tumor released exosomes and glutamatergic signalingR21CA185835 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI CHEN, SUZIE, GOYDOS, JAMES S. · 2015 to 2016
$371k
NCI NIH HHS R21 CA185835NIEHS NIH HHS R25 ES020721
6 · The paper itself

Abstract

Exosomes are naturally occurring membrane-bound nanovesicles generated constitutively and released by various cell types, and often in higher quantities by tumor cells. Exosomes may facilitate communication between the primary tumor and its local microenvironment, supporting cell invasion and other early events in metastasis. A neuronal receptor, metabotropic glutamate receptor 1 (GRM1), when ectopically expressed in melanocytes, induces

Indexed as

cancerexosomesGPCRGRM1melanoma

Identifiers

PMID29416686
PMCPMC5787429
OpenAlexW2776481835

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.